MRK
Merck & Co., Inc.
Merck & Co., Inc. (MRK) has 14 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 5, 2026.
Insiders have net sold $14.5M over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Robert Davis
- Employees:73,000
- HQ:Rahway, NJ, US
- IPO:1978-01-13
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14.5M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$315.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Zachary JenniferFirst filing | EVP, General Counsel | Sale | 121,573 | $14.5M | Feb 9 | SEC ↗ |
Congress trading MRK
See timeline →- RRep. Keith SelfSale$1,001 - $15,0002025-01-10
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
Merck & Co., Inc. is in the Healthcare sector.